These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 21786368)

  • 21. Comparison of biological activity among nonfucosylated therapeutic IgG1 antibodies with three different N-linked Fc oligosaccharides: the high-mannose, hybrid, and complex types.
    Kanda Y; Yamada T; Mori K; Okazaki A; Inoue M; Kitajima-Miyama K; Kuni-Kamochi R; Nakano R; Yano K; Kakita S; Shitara K; Satoh M
    Glycobiology; 2007 Jan; 17(1):104-18. PubMed ID: 17012310
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improved FcγRIIb targeting functionally translates into enhanced inhibition of basophil activation.
    Buschor P; Eggel A; Zellweger F; Stadler BM; Vogel M
    Int Arch Allergy Immunol; 2014; 163(3):206-14. PubMed ID: 24557487
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention of autoimmune diabetes by intramuscular gene therapy with a nonviral vector encoding an interferon-gamma receptor/IgG1 fusion protein.
    Prud'homme GJ; Chang Y
    Gene Ther; 1999 May; 6(5):771-7. PubMed ID: 10505100
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Post-secretion neutralization of transgene-derived effect: soluble erythropoietin receptor/IgG1Fc expressed in liver neutralizes erythropoietin produced in muscle.
    Maruyama H; Higuchi M; Higuchi N; Kameda S; Saito M; Sugawa M; Matsuzaki J; Neichi T; Yokoyama S; Miyazaki Y; Miyazaki J; Gejyo F
    J Gene Med; 2004 Feb; 6(2):228-37. PubMed ID: 14978776
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simultaneous engagement of FcgammaIIb and CD22 inhibitory receptors silences targeted B cells and suppresses autoimmune disease activity.
    Mihaylova N; Voynova E; Tchorbanov A; Dolashka-Angelova P; Bayry J; Devreese B; Kaveri S; Vassilev T
    Mol Immunol; 2009 Nov; 47(1):123-30. PubMed ID: 19243823
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fc optimization of therapeutic antibodies enhances their ability to kill tumor cells in vitro and controls tumor expansion in vivo via low-affinity activating Fcgamma receptors.
    Stavenhagen JB; Gorlatov S; Tuaillon N; Rankin CT; Li H; Burke S; Huang L; Vijh S; Johnson S; Bonvini E; Koenig S
    Cancer Res; 2007 Sep; 67(18):8882-90. PubMed ID: 17875730
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mono-PEGylated dimeric exendin-4 as high receptor binding and long-acting conjugates for type 2 anti-diabetes therapeutics.
    Kim TH; Jiang HH; Lee S; Youn YS; Park CW; Byun Y; Chen X; Lee KC
    Bioconjug Chem; 2011 Apr; 22(4):625-32. PubMed ID: 21401109
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Expression of TPO mimetic peptide chimeric proteins with human IgG1 Fc fragments and their biological characters].
    Li YX; Li C; Tao KH; Jia XH; Cheng DS; Huang PT
    Sheng Wu Gong Cheng Xue Bao; 2002 Jul; 18(4):424-30. PubMed ID: 12385237
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Binding of divalent H-2Kd/IgG2aFc fusion protein to murine macrophage via Fc-FcR interaction.
    Xiao W; Chen X; Lin Zhou ; Lu S; Liang Z; Wu X
    Cell Mol Immunol; 2007 Apr; 4(2):147-51. PubMed ID: 17571461
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Engineered antibody Fc variant with selectively enhanced FcγRIIb binding over both FcγRIIa(R131) and FcγRIIa(H131).
    Mimoto F; Katada H; Kadono S; Igawa T; Kuramochi T; Muraoka M; Wada Y; Haraya K; Miyazaki T; Hattori K
    Protein Eng Des Sel; 2013 Oct; 26(10):589-98. PubMed ID: 23744091
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibody-mediated coengagement of FcγRIIb and B cell receptor complex suppresses humoral immunity in systemic lupus erythematosus.
    Horton HM; Chu SY; Ortiz EC; Pong E; Cemerski S; Leung IW; Jacob N; Zalevsky J; Desjarlais JR; Stohl W; Szymkowski DE
    J Immunol; 2011 Apr; 186(7):4223-33. PubMed ID: 21357255
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Control of spontaneous B lymphocyte autoimmunity with adenovirus-encoded soluble TACI.
    Liu W; Szalai A; Zhao L; Liu D; Martin F; Kimberly RP; Zhou T; Carter RH
    Arthritis Rheum; 2004 Jun; 50(6):1884-96. PubMed ID: 15188365
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Expression of ATR-Fc fusion protein in CHO cells].
    Gao LH; Hu XW; Chen W; Xu JJ; Zhao J; Chen HP
    Sheng Wu Gong Cheng Xue Bao; 2005 Sep; 21(5):826-31. PubMed ID: 16285529
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression and ligand binding assays of soluble cytokine receptor-immunoglobulin fusion proteins.
    Brown SJ; Becherer KA; Blumeyer K; Kautzer C; Axelrod F; Le H; McConnell SJ; Whalley A; Spinella DG
    Protein Expr Purif; 1998 Oct; 14(1):120-4. PubMed ID: 9758759
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of B cells in vivo by a Fab/Fc fragment of a monoclonal anti-IgD antibody requires an interaction between the antibody fragment and a cellular IgG Fc receptor.
    Goroff DK; Finkelman FD
    J Immunol; 1988 May; 140(9):2919-24. PubMed ID: 2966202
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TNF receptor II fusion protein with tandemly repeated Fc domains.
    Nagashima H; Kaneko K; Yamanoi A; Motoi S; Konakahara S; Kohroki J; Masuho Y
    J Biochem; 2011 Mar; 149(3):337-46. PubMed ID: 21278157
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A recombinant mimetics of the HIV-1 gp41 prehairpin fusion intermediate fused with human IgG Fc fragment elicits neutralizing antibody response in the vaccinated mice.
    Qi Z; Pan C; Lu H; Shui Y; Li L; Li X; Xu X; Liu S; Jiang S
    Biochem Biophys Res Commun; 2010 Jul; 398(3):506-12. PubMed ID: 20599765
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combination B7-Fc fusion protein treatment and Treg cell depletion therapy.
    Liu A; Hu P; Khawli LA; Epstein AL
    Clin Cancer Res; 2005 Dec; 11(23):8492-502. PubMed ID: 16322313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surface display of IgG Fc on baculovirus vectors enhances binding to antigen-presenting cells and cell lines expressing Fc receptors.
    Martyn JC; Cardin AJ; Wines BD; Cendron A; Li S; Mackenzie J; Powell M; Gowans EJ
    Arch Virol; 2009; 154(7):1129-38. PubMed ID: 19557497
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Expression and Characterization of Single-chain Fv-Fc Fusion Protein against Human P185(erbB2)].
    Xie ZG; Guo N; Shi M; Feng JN; Yu M; Sun YX; Shen BF
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Apr; 35(4):371-4. PubMed ID: 12673393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.